Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Bonnert

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 26, 2012
Synthesis and evaluation of 8-oxoadenine derivatives as potent Toll-like receptor 7 agonists with high water solubilityTomoaki Nakamura, Hiroki Wada, Hirotaka Kurebayashi, et al.
Journal of Computer-Aided Molecular Design|November 2, 2011
In silico prediction of acyl glucuronide reactivityTim Potter, Richard Lewis, Tim Luker, et al.
Journal of Medicinal Chemistry|March 18, 2010
Synthesis and biological evaluation of 8-oxoadenine derivatives as toll-like receptor 7 agonists introducing the antedrug conceptAyumu Kurimoto, Kazuki Hashimoto, Tomoaki Nakamura, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2007
SAR studies on thiazolo[4,5-d]pyrimidine based CXCR2 antagonists involving a novel tandem displacement reactionFraser Hunt, Caroline Austin, Rupert Austin, et al.
Journal of Medicinal Chemistry|March 2, 2011
Zwitterionic CRTh2 antagonistsTim Luker, Roger Bonnert, Stuart W Paine, et al.
Bioorganic & Medicinal Chemistry Letters|February 2, 2008
Evaluation of a series of bicyclic CXCR2 antagonistsIain Walters, Caroline Austin, Rupert Austin, et al.
Bioorganic & Medicinal Chemistry Letters|September 28, 2011
Substituted indole-1-acetic acids as potent and selective CRTh2 antagonists-discovery of AZD1981Tim Luker, Roger Bonnert, Steve Brough, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2011
Switching between agonists and antagonists at CRTh2 in a series of highly potent and selective biaryl phenoxyacetic acidsTim Luker, Roger Bonnert, Jerzy Schmidt, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of AZD3199, An Inhaled Ultralong Acting β2 Receptor Agonist with Rapid Onset of ActionMichael J Stocks, Lilian Alcaraz, Andrew Bailey, et al.
Bioorganic & Medicinal Chemistry Letters|June 10, 2011
Design driven HtL: The discovery and synthesis of new high efficacy β₂-agonistsMichael J Stocks, Lilian Alcaraz, Andrew Bailey, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry Letters|December 26, 2012
Synthesis and evaluation of 8-oxoadenine derivatives as potent Toll-like receptor 7 agonists with high water solubilityTomoaki Nakamura, Hiroki Wada, Hirotaka Kurebayashi, et al.
Journal of Computer-Aided Molecular Design|November 2, 2011
In silico prediction of acyl glucuronide reactivityTim Potter, Richard Lewis, Tim Luker, et al.
Journal of Medicinal Chemistry|March 18, 2010
Synthesis and biological evaluation of 8-oxoadenine derivatives as toll-like receptor 7 agonists introducing the antedrug conceptAyumu Kurimoto, Kazuki Hashimoto, Tomoaki Nakamura, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2007
SAR studies on thiazolo[4,5-d]pyrimidine based CXCR2 antagonists involving a novel tandem displacement reactionFraser Hunt, Caroline Austin, Rupert Austin, et al.
Journal of Medicinal Chemistry|March 2, 2011
Zwitterionic CRTh2 antagonistsTim Luker, Roger Bonnert, Stuart W Paine, et al.
Bioorganic & Medicinal Chemistry Letters|February 2, 2008
Evaluation of a series of bicyclic CXCR2 antagonistsIain Walters, Caroline Austin, Rupert Austin, et al.
Bioorganic & Medicinal Chemistry Letters|September 28, 2011
Substituted indole-1-acetic acids as potent and selective CRTh2 antagonists-discovery of AZD1981Tim Luker, Roger Bonnert, Steve Brough, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2011
Switching between agonists and antagonists at CRTh2 in a series of highly potent and selective biaryl phenoxyacetic acidsTim Luker, Roger Bonnert, Jerzy Schmidt, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of AZD3199, An Inhaled Ultralong Acting β2 Receptor Agonist with Rapid Onset of ActionMichael J Stocks, Lilian Alcaraz, Andrew Bailey, et al.
Bioorganic & Medicinal Chemistry Letters|June 10, 2011
Design driven HtL: The discovery and synthesis of new high efficacy β₂-agonistsMichael J Stocks, Lilian Alcaraz, Andrew Bailey, et al.
Pageof 2